Analysis

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis

Supernus Pharmaceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to SUPN.

websiteSUPN/analysis/SUPN

Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to SUPN.

Stock profile

Ticker

SUPN

Asset type

Stock

Market cap

$2.58B

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

USD

Ticker listings

Supernus Pharmaceuticals, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • SUPN primary listing
  • A1JX3U
  • S49
  • 0LB2

Latest Supernus Pharmaceuticals, Inc. news

Supernus Expands Partnership With MERGE as AI-Powered Agency of Record

Engagement Includes CNS Portfolio and Digital EcosystemCHICAGO, June 17, 2026 (GLOBE NEWSWIRE) -- MERGE announces its selection as the Agency of Record (AOR) for Supernus Pharma...

Supernus Pharmaceuticals to Participate in June Investor Conferences

ROCKVILLE, Md., May 27, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products fo...

Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference

ROCKVILLE, Md., May 06, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products fo...

Supernus Announces First Quarter 2026 Financial Results

Total revenues were $207.7 million in the first quarter 2026, a 39% increase compared to same period last year.Combined revenues of the Company's four growth products increased ...

Supernus Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 5, 2026

ROCKVILLE, Md., April 22, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products ...

Research sections

Valuation

Review valuation context for Supernus Pharmaceuticals, Inc..

Future growth

Review future growth context for Supernus Pharmaceuticals, Inc..

Past performance

Review past performance context for Supernus Pharmaceuticals, Inc..

Financial health

Review financial health context for Supernus Pharmaceuticals, Inc..

Dividend

Review dividend context for Supernus Pharmaceuticals, Inc..

Management

Review management context for Supernus Pharmaceuticals, Inc..

Ownership

Review ownership context for Supernus Pharmaceuticals, Inc..

Other information

Review other information context for Supernus Pharmaceuticals, Inc..

Community

Review community context for Supernus Pharmaceuticals, Inc..